Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?

To: StockDung who wrote (15762)	9/19/2005 11:50:42 AM
From: scion	Read Replies (1) \| Respond to of 19428

THOMAS C. RONK (TCR) - Wall Street Hire Report esynergies.com Institutional Research…………….………………... Sector: BioTech, Pharma & Technology Strong Hire Recommendation For: THOMAS C. RONK (TCR) 417 ORCHID AVE. CORONA DEL MAR, CA 92625 PH: 800-715-9999 EMAIL: TRONK@ADELPHIA.NETBACKGROUND eSynergies (CEO)......................1999-2002 HealthStar (CEO)......................1998-1999Market Stratagems (Analyst) .....1994-2001 Transamerica (Series 7) .............1992-1998 Bison Financial (VP).................1989-1994 Univ. of CA, San Diego.............1986-1990 COVERAGE HISTORYSectorYearBioTech / Pharma.……………………2002Healthcare................................ 1996-1999Technology/Internet .................. 1994-2001M&A TRANSACTIONS Nutra Pharma Acquires Bio Ther…$45 MM eSynergies Acquires Salesmation ...$45 MM Gatwick Acquires Aim Smart.......$100 MM Champion Acquires HealthStar…….$8 MM FUNDRAISING eSynergies…..……………….…....$11MM Aim Smart…………………...……S10MM HealthStar.....................................$10MM Transamerica……....………...…..$250MM Bison Financial…….……….……$300MM Wall Street veteran with 14 years broad experience in: buy-side and sell-side fundamental and technical research, mergers and acquisitions,corporate finance, venture capital, PIPEs, IPOs, asset management, trading, options, syndication, fixed income, SEC filings, corporate accounting,securities law, contract law, bankruptcy code, shareholder communications, strategic partnerships, international affairs, government relations, licensing, manufacturing, sales, distribution and intellectual property. BioTech / Pharma: Designed and implemented acquisition strategy for Nutra Pharma Corp, a publicly traded biopharma company. Negotiated $45 million acquisition of Bio Therapeutics Inc. in August 2002. Market Cap reached $160 million. Negotiated acquisition of Receptopharm in Dec. 2003 Technology / Internet: Founded web-based marketing automationcompany, Salesmation and acquired M2 Limited (online translation) and Commerce Switch (B2B exchange). Sold to publicly traded eSynergies, Inc. for $45 million. Became eSynergies CEO, first quarter in office was profitable, acquired Worldwide Xceed Group (billion dollar interactiveagency) and e2 Communications (email marketing service provider).Negotiated 3 Chapter 11 proceedings (purchased one company, sold one company, one still pending). Negotiated Gatwick acquisition of Aim Smart Corporation and subsequent public trading up to $350 million market cap. Healthcare: Designed and implemented acquisition strategy for Champion Financial. Sales increased from $600,000 to $17 million with acquisition of HealthStar, Inc. Split adjusted stock price reached $25 per share. As CEO of HealthStar, managed 120,000 doctor PPO and sold it to Beyond Benefits. Airline / Travel: Research on RCG increased market cap from $7MM to $41MM in 4 months. Volume increased by 12MM+ shares, providing financing for acquisition of SunTrips/Vacation Express with $200MM revs. Research Collaborations: Interviewed by Sue Herrera and Don Dahler on CNBC regarding Internet research. Co-authored articles with Peter Henig of RedHerring, Thom Calandra of CBS MarketWatch and MSNBC.Registered Analyst for Investor’s Business Daily.</html